These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

885 related items for PubMed ID: 8976219

  • 1. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
    Rosen EM, Joseph A, Jin L, Yao Y, Chau MH, Fuchs A, Gomella L, Hastings H, Goldberg ID, Weiss GH.
    J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
    Durkan GC, Nutt JE, Rajjayabun PH, Neal DE, Lunec J, Mellon JK.
    Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
    [Abstract] [Full Text] [Related]

  • 3. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 4. Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma.
    Casella R, Shariat SF, Monoski MA, Lerner SP.
    Cancer; 2002 Dec 15; 95(12):2494-9. PubMed ID: 12467062
    [Abstract] [Full Text] [Related]

  • 5. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.
    Shi B, Laudon V, Yu S, Dong D, Zhu Y, Xu Z.
    Urol Int; 2008 Dec 15; 81(3):320-4. PubMed ID: 18931551
    [Abstract] [Full Text] [Related]

  • 6. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 May 15; 416():1-482. PubMed ID: 12616295
    [Abstract] [Full Text] [Related]

  • 7. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
    King ED, Matteson J, Jacobs SC, Kyprianou N.
    J Urol; 1996 Jan 15; 155(1):316-20. PubMed ID: 7490878
    [Abstract] [Full Text] [Related]

  • 8. Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer.
    Tzai TS, Tsai YS, Shiau AL, Wu CL, Shieh GS, Tsai HT.
    Urology; 2006 Feb 15; 67(2):294-9. PubMed ID: 16461079
    [Abstract] [Full Text] [Related]

  • 9. [Expression and clinical significance of nuclear matrix protein 22 and cytokeratin 18 in transitional cell carcinoma of the bladder].
    Song JW, DU LL, Zhao XW, Jing JX, Han CZ, Cui Y, Liu JW, Hao HL, Wang ZG, Mi ZG.
    Zhonghua Zhong Liu Za Zhi; 2009 Apr 15; 31(4):274-7. PubMed ID: 19615282
    [Abstract] [Full Text] [Related]

  • 10. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC, Fine SW, Epstein JI.
    Am J Surg Pathol; 2006 Jul 15; 30(7):883-91. PubMed ID: 16819332
    [Abstract] [Full Text] [Related]

  • 11. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F, Müller M, Schostak M, Soong R, Tabiti K, Miller K.
    Urology; 2004 Jul 15; 64(1):157-61. PubMed ID: 15245962
    [Abstract] [Full Text] [Related]

  • 12. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM, García Rodríguez J, Escaf Barmadah S, Raigoso P, Rodríguez Martínez JJ, Allende MT, Casasola Chamorro J, Rodríguez Faba O, Martín Benito JL, Regadera Sejas FJ.
    Arch Esp Urol; 2002 Jul 15; 55(1):41-9. PubMed ID: 11957750
    [Abstract] [Full Text] [Related]

  • 13. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP, Clark P, Miranda G, Cai J, Groshen S, Skinner DG.
    J Urol; 2005 Apr 15; 173(4):1163-8. PubMed ID: 15758728
    [Abstract] [Full Text] [Related]

  • 14. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T, Nesi G, Boddi V, Mazzoli S, Dal Canto M, Bartoletti R.
    Oncol Rep; 2006 Aug 15; 16(2):329-34. PubMed ID: 16820911
    [Abstract] [Full Text] [Related]

  • 15. Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer.
    Pham HT, Block NL, Lokeshwar VB.
    Cancer Res; 1997 Feb 15; 57(4):778-83. PubMed ID: 9044860
    [Abstract] [Full Text] [Related]

  • 16. Initial evaluation of the diagnostic performance of the new urinary bladder cancer antigen test as a tumor marker for transitional cell carcinoma of the bladder.
    Sánchez-Carbayo M, Herrero E, Megias J, Mira A, Espasa A, Chinchilla V, Soria F.
    J Urol; 1999 Apr 15; 161(4):1110-5. PubMed ID: 10081849
    [Abstract] [Full Text] [Related]

  • 17. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M.
    Ann Acad Med Stetin; 2000 Apr 15; 46():217-29. PubMed ID: 11712306
    [Abstract] [Full Text] [Related]

  • 18. Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer.
    Durkan GC, Nutt JE, Marsh C, Rajjayabun PH, Robinson MC, Neal DE, Lunec J, Mellon JK.
    Clin Cancer Res; 2003 Jul 15; 9(7):2576-82. PubMed ID: 12855633
    [Abstract] [Full Text] [Related]

  • 19. Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder.
    Shariat SF, Matsumoto K, Casella R, Jian W, Lerner SP.
    Eur Urol; 2005 Jul 15; 48(1):69-76. PubMed ID: 15967254
    [Abstract] [Full Text] [Related]

  • 20. Testing for urinary hyaluronate improves detection and grading of transitional cell carcinoma.
    Passerotti CC, Srougi M, Bomfim AC, Martins JR, Leite KR, Dos Reis ST, Sampaio LO, Ortiz V, Dietrich CP, Nader HB.
    Urol Oncol; 2011 Jul 15; 29(6):710-5. PubMed ID: 19962919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.